FCGR2A and neoplasm: These results importantly offer an immune-engaging alternative compared to HER3-ADCs, as FcγR-mediated responses can impact beyond direct tumor elimination by effector cells, through eliciting adaptive long-lasting anti-tumor vaccination effects [58].